Zeng Li Yang
Chief Executive Officer chez AUTOBIO DIAGNOSTICS CO., LTD.
Postes actifs de Zeng Li Yang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AUTOBIO DIAGNOSTICS CO., LTD. | Director/Board Member | 13/11/2012 | - |
| Chief Executive Officer | 29/10/2018 | - | |
| Corporate Officer/Principal | 13/11/2012 | 29/10/2018 | |
Autobio Biochemistry Co., Ltd.
 Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Director/Board Member | - | - |
Historique de carrière de Zeng Li Yang
Statistiques
Internationale
| Chine | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AUTOBIO DIAGNOSTICS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Health Technology |
- Bourse
- Insiders
- Zeng Li Yang
- Expérience
